Intercure Ltd.
INCR · XNASCIK 1857030fmd_0AC5BYA9NSHB3DBSA74XVP38MNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 7 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total revenues | 9 | 65 | 220 | 389 | 356 | 239 |
| Cost of revenue | 7 | 35 | 124 | 230 | 247 | 203 |
| Gross profit | 1 | 32 | 91 | 155 | 105 | 30 |
| Research and development | 2 | 2 | 1 | 1 | 0 | 0 |
| Selling, general and administrative | 15 | 17 | 50 | 93 | 96 | 108 |
| Operating income | (3) | (38) | 28 | 51 | (42) | (67) |
| Income before taxes | (7) | (38) | 19 | 44 | (61) | (87) |
| Income tax expense | (1) | (2) | 11 | 0 | 2 | (15) |
| Net income from continuing operations | (6) | (36) | 7 | 44 | (64) | (73) |
| Net income | (6) | (37) | 5 | 45 | (62) | (68) |